Skip to Main Content

Prediction of amyloid positivity using automated segmentation

By Cortechs.ai

2 mins

Prediction of amyloid positivity in mild cognitive impairment using fully automated brain segmentation software

The objective of this study was to assess the predictive ability of regional volume information provided by fully automated brain segmentation software for cerebral amyloid positivity in mild cognitive impairment (MCI). (2020).

Download

Share

Topic
Published research
Disease
Mild cognitive impairment

Insights

2 mins

Apr 26 2024

Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software

Read more about Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software

Cortechs.ai news

3 mins

Apr 3 2024

Cortechs.ai Appoints Kyle Frye as New Chief Executive Officer

Read more about Cortechs.ai Appoints Kyle Frye as New Chief Executive Officer

Cortechs.ai news

2 mins

Nov 21 2023

Our Normative Database

Whitepaper: How Cortechs.ai's normative database was created to accurately compare an individual’s brain structure volume to a healthy population.

Whitepapers

View our insights